A new market access negative list will be tested in selected regions starting in December. It will be applied nationwide in 2018 along with one just for foreign investment as China further opens its gates
Cloud computing service providers in China have to actively remove copyright-infringing content from their networks and put in place systems to prevent users from sharing such works. Rights owners welcome the development but data privacy concerns emerge
More tax deductions are available for R&D expenses, technology transfers can get exempted from enterprise income tax and insurance companies no longer require CIRC approval to set up rep offices overseas
The latest revisions increase corruption penalties, allow for subjective decisions and widen the information security net as China intensifies crackdown
This week the FDA found Pfizer's plant in China falsified records and used old ingredients, a U.S. defense group report questioned IBM, Cisco and Microsoft's local partnerships and China's leading travel service companies combined
This week the FDA found Pfizer's plant in China falsified records and used old ingredients, a U.S. defense group report questioned the local partnerships of IBM, Cisco and Microsoft and China's leading travel service companies combined
The State Council has unveiled a negative list system for market access, stricter environmental criteria have been set for construction projects and copyright measures have been imposed on cloud storage service providers
This week Chinese leaders met to approve the next Five-Year Plan, officials were told by the IMF that the RMB is likely to join the reserve currencies basket and the merger control regulator allowed Western Digital and Hitachi to combine research and manufacturing
The PRC Insurance Law is being amended, the PBOC has granted foreign central banks access to its interbank FX market and has lowered the threshold for MNCs' cross-border renminbi cash pooling
This week China issued draft rules for private car-hailing services, Volkswagen's global emissions scandal hit China and Eli Lilly and Innovent further collaborated on cancer drugs
